chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had a red spot at the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (had a red spot at the site of the injection) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Dementia and Cirrhosis of liver.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (had a red spot at the site of the injection). At the time of the report, VACCINATION SITE ERYTHEMA (had a red spot at the site of the injection) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was provided. The patient had Cirrhosis of the liver and dementia before receiving her first primary dose of the Moderna Covid-19 vaccine. No treatment information was provided.   This case was linked to MOD-2022-576601 (Patient Link).
pt recv vax 13JAN97 & 30MAR97 MD noted pt devel a few small red marks;devel 1 on each arm & a few on face;few had scabbed over;dx chickenpox was made;also devel rt OM;
At about 3am on 5/23/22 (received vaccine at 5pm on 5/20/22) when I was sleeping and turned over I experienced vertigo, strong sense of motion and spinning, I was able to sleep but this happened several times throughout the night. Upon waking I could steady myself but it was feeling of disequilibrium, off balance and wobbly throughout the morning, although I could work, also had some nausea and very mild diarrhea. I was able to eat and hydrate and by mid-day I was not nauseous but still unsteady but not as bad as in the morning. By nighttime that day it was improved. On 5/24/22, still have dizziness and mild unsteadiness at times, no gi problems.  This was my second booster and I have never experienced this before and have no reason to link it to anything else, I had not been anywhere since receiving the booster nor eaten or drank anything out of the usual. I have no underlying health conditions.
Pt had first Pfizer Covid vaccine on 01/08/2021 Lot: EL140. Pt reported that symptoms of fever and cough began on 08/07/2021. On 08/09/2021, pt went to ER and tested positive for Covid. Called the office on 08/11/2021 to report Covid symptoms; advised to call hospital and arrange for Monoclonal Antibody Therapy. Also, to return to ER if symptoms worsen. Coroner's office was called on 08/12/2021 per friend after well check by PD. Explained to clerk at  Coroner's Office what VAERS Reporting entails.  Clerk was unsure and asked that clinic submit report. Autopsy Report signed on 11/03/2021 Findings: 1. Complications of Covid-19 infection A. Positive NP swab for covid B. Several day history of fever. 2. Diabetes mellitus and kidney failure
Patient admitted to hospital 4/14/2022 on Observation Status with complaints of sinus congestion/nasal discharge, myalgias, and intractable n/v.  He was found to be in DKA as he had not been able to keep anything down so hadn't taken any insulin for a couple days.  Patient was tested for COVID upon hospital admission and this did come back Positive.
REDNESS, SWOLLEN AND HOT IN THE INJECTION SITE. BENADRYL AND IBUPROFEN. PATIENT ALSO HAD TO SEE A DOCTOR AND GOT STEROID SHOT.
Received first vaccine on 11/08/2006  never reported it until 03/01/. Area where she got Gardasil injection and tender and Hypo-pigmented.    Left Arm 32mm x 24 mm 11/08/2006 Right Arm 22 x 25 mm 01/08/2007
NAUSEA; HEADACHE; FEVER; BODY SHAKING; CHILLS; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802068, and batch number: 1802068 expiry: 25-MAY-2021) .5 ml, administered on 06-MAR-2021 14:00 for prophylactic vaccination. No concomitant medications were reported. On 06-MAR-2021 15:00, the subject experienced fatigue. On 06-MAR-2021 19:00, the subject experienced body shaking. On 06-MAR-2021 19:00, the subject experienced chills. On 07-MAR-2021, treatment medications included: butalbital/caffeine/paracetamol, ibuprofen, and ondansetron. On 07-MAR-2021 03:00, the subject experienced nausea. On 07-MAR-2021 03:00, the subject experienced headache. On 07-MAR-2021 03:00, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 100.7. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body shaking, chills, fatigue, nausea, and headache on 07-MAR-2021, and the outcome of fever was not reported. This report was non-serious. This report was associated with a product quality complaint: 90000172187. The suspected product quality complaint has been confirmed to be no pqc was identified within the reported complaint case. based on the PQC evaluation/investigation performed.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: Patient received 1st dose of her COVID vaccine.  She fainted about 10 minutes after receiving the vaccine while sitting in the chair.  EMS was called and she was taken to the emergency room in an ambulance.
Covid positive/ testing positive for the virus/ asymptomatic; Covid positive/ testing positive for the virus/ asymptomatic; This is a spontaneous report from a contactable consumer who reported for herself. A 30-year-old female consumer received her first single dose of BNT162B2 (Pfizer/ BioNTech Covid-19 vaccine, Lot number: EH9899) on 17Dec2020 per works recommendation (COVID-19 immunization). The patient had a history of back pain and had no concomitant medications. The patient got the vaccine and tested for Covid as a preventative to make sure she was safe to travel for a wedding. Her Covid test was pending and she found out that she was Covid positive the day after receiving her first dose of the Pfizer Covid vaccine. Her primary care informed her to get the booster despite testing positive for the virus. She was told since she was asymptomatic that she could get the vaccine. She received the second dose on 04Jan2021. The outcome of the event Covid positive was not reported.
Received shot at 12:30 PM. Started feeling really tired about 8:30 PM. Severe body aches and chills at 9:30 PM. Wearing layers under blankets and teeth chattering. Started getting a headache. Took Aleve 440 mg at 11:00 PM, did not help. Sleep at midnight, woke at 2:30 freezing and very achy. Woke again at 0630 same symptoms, woke again at 11:00 AM, severe aches, headache, but being so cold was subsiding. Highest temp I had during this was 99.7, so not bad. Felt tired and very achy all day Thursday arm is red and have other red areas now on that arm that are hot and painful, no more chilling. Just feeling tired Friday and still have the red spots on the arm by the injection site. Aches and headache subsided. I still had a post Covid cough and palpitations when I received the vaccine.
Headache, Myalgia, Arthralgia, Rash, UrticariaPruritus & NauseaVomiting Narrative:  Other Relevant History:
Typical fatigue , fever (99.6F), aches beginning approximately 9 hours after vaccine  PLUS Atypical frequent urination(averaging every hour and a half) and left neck lymphnode swollen/sore beginning approximately 9 hours after vaccine and lasting approximately 21 hours. Both subsided at same time as fever and aches. Fatigue lasted for an additional 18 hours.
I had received the J&J COVID vaccine when I was 13 weeks and 3 days pregnant on 09/23/2021. My baby was born at 7lbs 5oz.  My child was both with a bilateral corneal opacity. She?s been treated with the corneal disease ophthalmologist (contact information provided) since 1 month of age. This birth defect was noticed 5 minutes after birth. The ophthalmologist believes this birth defect occurred between 12-14 weeks pregnant and as stated before,  I had the J&J shot at 13 weeks. It is not certain there is a connection but I feel it is worth reporting being that the vaccine and the window that the birth defect was suspected to have occurred overlap.
i have the flu never been so sick; I have the flu never been so sick; Initial information received on 30-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-health care professional.  This case involves an adult patient of unknown gender who have the flu never been so sick and i have the flu never been so sick after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It is unknown if the patient had any medical history, concomitant disease or risk factor.   On an unknown date, the patient received a unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number, expiry date, strength, formulation, route was unknown) in unknown administration site for prophylactic vaccination(Immunisation). Information regarding batch number details has been requested.  On an unknown date the patient had non-serious events of  i have the flu never been so sick (influenza) (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  It is unknown if there were lab data/results available.   Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events (i have the flu never been so sick, I have the flu never been so sick).  Outcome was Unknown for both the events.
vaccination failure; shingles on his right forehead, scalp, and temple; Body aches; Fatigue; flu like; Body aches; Fatigue; flu like; This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had shingles two years before the date of reporting). Previously administered products included Shingles vaccine (had a shingles vaccination sometime before that outbreak).   In March 2018, the patient received the 1st dose of Shingrix. In September 2018, the patient received the 2nd dose of Shingrix. In March 2018, less than a day after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced general body pain, fatigue and influenza-like symptoms. In September 2018, the patient experienced general body pain, fatigue and influenza-like symptoms. In August 2019, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the vaccination failure, shingles, general body pain, fatigue and influenza-like symptoms were unknown and the outcome of the general body pain, fatigue and influenza-like symptoms were recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles, general body pain, fatigue and influenza-like symptoms to be related to Shingrix. It was unknown if the reporter considered the vaccination failure, shingles, general body pain, fatigue and influenza-like symptoms to be related to Shingrix.  Additional details were reported as follows: At the time of reporting, the patient experienced shingles on his right forehead, scalp, and temple. Within a few hours after receiving both the doses of Shingrix, the patient experienced flu-like symptoms which included body aches and fatigue. The symptoms lasted for 1.5 days after receiving 1st dose of Shingrix.  The reporter gave permission for his physician to be contacted. The reporter was unable to obtain additional information.
TOOK ONLY TWO DOSE; This spontaneous case report was received from a consumer (PVX2019-715) on 23-Mar-2019. It described a male consumer who "took only two doses". The consumer was receiving Vivotif for an unknown indication.  It was reported that the consumer took only first two doses of Vivotif on Wednesday and Friday, respectively. Then, the consumer went to country and forgot to bring the remaining doses. The consumer will be coming back on next Wednesday.  The action taken with Vivotif with respect to the event "took only two doses" was not applicable.  The clinical outcome of the event "took only two doses" was unknown.  Company's Comment: The causality of the event "took only two doses" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took only two dose" was considered as not applicable.
Downward decline in mental capacity. It was going to come with his condition (alzheimers disease) but there's been a significant turn for the worst since he took the vaccine. It was evidentiary approximately 6 weeks after his second and final vaccination.
Shivering; Dizziness; heart palpitations; This case was reported by a consumer via call center representative and described the occurrence of shivering in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced shivering, dizziness and palpitation. On an unknown date, the outcome of the shivering, dizziness and palpitation were unknown.   It was unknown if the reporter considered the shivering, dizziness and palpitation to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The case was reported by patient's husband. The reporter stated that, the patient received the Shingrix vaccine at a pharmacy and had a multiple adverse reactions. The reporter did not provide additional information to document the adverse event. The events reported were shivering, dizziness and heart palpitations. The reporter did not consent to follow up.
Stroke like symptoms, facial drooping left side, r/o CVA, TIA, r/o Bell?s Palsey, went to ER and was transferred to alternate Hospital for possible stroke.
twice, I´ve had the shots also / suspected vaccination failure; twice, not goog; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient had vaccine twice and it was not good, patient had the shots also. This case was considered as suspected vaccination failure, as details regarding laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.
This spontaneous report as received from a other health professional. The primary reporter is a nurse who states the same expired GARDASIL lot # (666595/0096Z) expiration date 14Oct2012, was administered to 3 clients. This was the second dose in the GARDASIL series for all three clients, and they were vaccinated on 30Nov2012. Client one, vaccinated in left deltoid. No other co-suspects were reported. No treatment information was reported. All drop down boxes apply to all three clients. No concomitant medications were reported. No other information was provided.
6/12/01 complained of injection site being sore immediately, post vax. The following AM, 6/13/01, temperature was 101F and complained of a headache, neck and back pain and swollen glands. Arm site ok, no redness or soreness. 6/14/01, all symptoms gone.
pt recv vax & devel high pitched crying for 3hr, fever of 104 & pain @ the site of vax;2 days post vax pt was treated for an ear infect;pt had recovered @ the date of this report; this is 1 of 3 pt;
Client was present in the clinic for his booster dose of Moderna (Lot # 078J21A), which was received to the LD at 1334 on 1-6-2022. Immediately after vaccination, he reported that he felt dizzy when he attempted to stand and that it was ?hard to talk?. He did not present with LOC, pallor, or diaphoresis. He was assisted to sit again and was provided/consumed juice. After a short while, he was assisted to walk to the cot and laid himself down. He reported that he felt much better laying down. VS at 1345 were: BP 130/68 laying, HR 84, SPO2 97% RA.  He continued to lay down and recover. Upon inquiry, he reported that he had had enough to eat/drink before vaccination and that he?d never had a reaction like this before. Education on vasovagal responses, safety and when to seek out medical care was provided. At 1354, he reported that he felt ?fine- everything is okay?. VS at this time were BP 128/62 laying, HR 82, SPO2 97% on RA.  At 1355, he sat at the edge of the cot without difficulty and then transitioned to standing. He reported that he felt ?okay? and had no dizziness while standing. His VS standing were: BP 125/57, HR 83, SPO2 97% on RA. At 1356, he settled in a chair. He did report that he has a history of vertigo and orthostatic hypotension and anxiety r/t injections.  At 1409, he reported he felt ?Fine. My head, body everything is okay. I?m not dizzy, I?m 100% normal.? His VS at this time were: BP 122/55 sitting, HR 80, SPO2 97% on RA. He was provided education on safety and was encouraged his phone with him and to take extreme caution while driving. He remained in clinic under observation until 1415, at which point he the exited facility.
SHORTNESS OF BREATH, chest pain, palpitations, night sweats, dizziness, body aches, chills, headache
Red-warm induration noted to left deltoid area. Ice compresses: left upper arm. Meds: Cephalexin 250 mg tsp TID for 5 days, Benadryl 1.5 tsp every 8 hours. Return for follow up in 24 hours if more symptoms. 8/18/03 10:00 called mom to see how pt is doing and states no more redness or swelling to site.
felt horrible day after 1st one; This case was reported by a consumer and described the occurrence of feeling bad in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced feeling bad. On an unknown date, the outcome of the feeling bad was unknown.   It was unknown if the reporter considered the feeling bad to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but it was captured as adult as per vaccine indication. The patient felt horrible day after 1st dose.  The patient received 2nd shot (6 months apart). Second one was supposed to be worse but felt fine day after.  The patient stated that he or she knew people who had shingles and he or she did not want shingles.
102.4F which lasted past 24hrs, gradually lowering without any fever reducing medications. Ended after about 36hrs+ Extreme back pain Extreme Head ache mild nausea when on an empty stomach
3/22/03 Tingling fingertips, 03/23/03 numbness hands, thighs to chest. 03/24/03 went to ER, 1 week later symptoms subsided slowly and referred to a neurologist who tested pt. Based on test results concluded the Typhoid vaccine was the precipitating cause of acute Guillain Barre syndrome.
PATIENT REPORTED PAIN AND SORNESS IN LEFT ARM (INJECTION SITE) AND ALSO AROUND LEFT BREAST, WITH A PAIN SCORE OF 8/10, REPORTED SHE STARTED GETTING COLD AND TIRED AFTER SHINGRIX BOOSTER VACCINE WAS ADMINISTERED, SYMPTOMS STARTED AFTER 6 HOURS. PATIENT HAS TAKEN 2 ACETAMINOPHEN 500MG TABLETS TO HELP ALLEVIATE THE PAIN AND DRINKING HOT TEA(S), WHILE RESTING IN BED. WILL CONTINUE TO REST AND HYDRATE, TAKE OTC PAIN RELIEVERS AND FEVER REDUCERS UNTIL ALL THE SYMPTOMS HAVE COMPLETELY DECLINED.   PATIENT REPORTED SHE FELT THE SAME SYMPTOMS AFTER THE FIRST SHINGRIX VACCINE, HOWEVER THE SYMPTOMS WHERE WAY MILDER AND MORE TOLERABLE THAN THE SECOND TIME.
Information has been received from a physician concerning a "1 year old" female who on 10-JUL-2007 was vaccinated subcutaneously with the first dose of varicella virus vaccine live (Oka/Merck). Subsequently the patient experienced "local injection site reaction that was hard, swollen, red and feverish to the touch". The patient sought unspecified medical attention. The patient was treated with diphenhydramine hydrochloride (BENADRYL) and the reaction had cleared up. Subsequently, the patient recovered from "local injection site reaction that was hard, swollen, red and feverish to the touch". No product quality complaint was involved. Follow up information was received from a physician who reports that 12 month old white female, with no pertinent medical history or allergies was vaccinated subcutaneously into the "left quad" with a first dose of varicella virus vaccine live (Oka/Merck) ("Lot # 04464") at 15:00 on 10-JUL-2007. Concomitant vaccine therapy that same day included a fourth dose, intramuscularly, into the right quad with diphtheria toxoid (+) pertussis acellular 1-component vaccine (+) poliovirus vaccine inactivated (Verol (+) tetanus toxoid (DTAP-IPV) (Lot # C2655AAFM) and a fourth dose, intramuscularly, into the right quad with pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (PREVNAR) (Lot # B58845H-FM). There was no illness at the time of vaccination. On 20-JUL-2007 the patient experienced swelling, redness and pustules at the sight of the injection. On 22 JUL 2007 the patient recovered from the swelling, redness and pustules at the right of the injection. The patient did not experience any adverse events following prior vaccinations. No diagnostic lab tests were performed.
One hive over left eye. denies swelling, SOB, tingling, and itching. benadryl given, symptoms improved
ADMINISTRATION OF AN EXPIRED VACCINE; This spontaneous report received from a pharmacist concerned a 49 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 206A21A, expiry: 21-SEP-20201) dose was not reported, administered on 22-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 22-SEP-2021, the patient experienced administration of an expired vaccine. The action taken with covid-19 vaccine was not applicable. The outcome of administration of an expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20210958321, 20210958423, 20210958716, 20210958502, 20210958405, 20210958366, 20210958249, 20210958993.  .
Dizziness and fatigue began immediately after receiving the dose (lasting about 2 days). On day 3, the dizziness subsided but I began to have mild discomfort in my chest. On day 6 (09/18/2021), I went to the emergency room because the discomfort did not improve or worsen. EKG and bloodwork did not show signs of heart attack, myocarditis, or pericarditis, and the doctor was unable to pinpoint the cause of it (aside from mentioning a delayed reaction to the vaccine). The discomfort subsided on day 9 (09/21/2021).
About 3 hrs post/vax, symptoms of shooting pains in her abdomen some hot flashes & also diarrhea. Also, had eaten dinner during those 3 hrs. She called ER but was not seen. She states was fine after an hour or so.